Zydus Lifesciences reports 24% rise in Q3 consolidated net profit

03 Feb 2023 Evaluate

Zydus Lifesciences has reported results for third quarter ended December 31, 2022.

The company has reported 29.90% rise in its net profit at Rs 255.90 crore for Q3FY23 as compared to Rs 197.00 crore for the corresponding quarter previous year. Total income of the company increased by 19.77% to Rs 2223.20 crore for the quarter under review as compared to Rs 1856.20 crore for the same quarter in the previous year.

On the consolidated basis, the company has reported rise of 24.48% in its net profit at Rs 622.90 crore for Q3FY23 as compared to Rs 500.40 crore for the same quarter in the previous year. Total income of the company increased by 18.92% to Rs 4400.80 crore for the quarter under review as compared to Rs 3700.50 crore for the same quarter in the previous year.

Zydus Lifesciences Share Price

867.80 -16.20 (-1.83%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×